ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010